Home ICON Views & Blog Emerging Markets Investigators Contact ICON Excellence SERVICES THERAPEUTICS INNOVATION INVESTORS NEWS & EVENTS CAREERS Gastrointestinal ICON has experience in managing clinical studies in all major gastrointestinal indications. Oncology Clinical Trials Central Nervous System Endocrine & Metabolic Disorders Infectious Disease & Vaccines Cardiovascular Transplant & Immunology Gastrointestinal Biosimilars Other Areas of Expertise Medical Device ICON plc - Clinical Research Organisation (CRO) for Drug Development » Therapeutics » Gastrointestinal Gastrointestinal ICON has extensive experience in conducting gastrointestinal studies across the entire drug development spectrum, ranging from the initial studies in Phase I through post-marketing efforts in Phase IV. In the past five years, ICON has conducted approximately 80 clinical gastrointestinal studies, assessing over 18,500 patients at 3,600 sites worldwide. Related Information Register as an ICON Investigator for Gastrointestinal studies » Related News ICON Announces Senior Clinical and Laboratory Appointments » ICON Strengthens Global Scientific Council with the Appointments of Professor Brendan Buckley and Dr. Nicholas Alp » ICON Selected by Shire plc’s Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services » ICON Announces Asia Pacific Seminar Series » More news » Our clinical trial experience includes but is not limited to the following gastrointestinal indications: Acute Pancreatitis Colorectal Conditions Constipation Crohn’s Disease Inflammatory Bowel Disease Irritable Bowel Disease Diarrhea Dyspepsia Gastroenteritic Infections Gastroesophageal Reflux Liver Cirrhosis Esophagitis Ulcerative Colitis Investigative Sites Our global investigator database includes over 1,500 gastrointestinal investigative sites across 50 countries. We have worked with a wealth of specialty investigators in the areas of Abdominal Hernias, Anal and Rectal Conditions, Benign GI Neoplasms, Infections, Inflammations, Motility, Stenosis, Ulceration and Vascular Conditions, Diverticular Disorders, Exocrine Pancreatic Disorders, GI Hemorrhages, Malabsorption, Perotineal and Retroperitoneal Conditions, Salivary Gland Conditions, Tongue Conditions, and Oral Soft Tissue Conditions. Gastrointestinal TAG (Therapeutic Area Group) ICON’s Gastrointestinal TAG is comprised of internal therapeutic specialists who are experienced in clinical research and drug development. The Gastrointestinal TAG contains networks with thought leaders, investigators, and clinical professionals throughout the world who are available to consult on individual projects. In addition to providing support and guidance to the study team, the main responsibilities of the TAG teams include: Global project feasibility Protocol development, review and evaluation Clinical trial planning Therapeutic training and advice Project oversight Consulting, medical monitoring and advisory board representation Interpretation of the clinical data A 24-hour, global physician “on call” system to assure that no enrollment opportunity is missed Print page Email to a friend Twitter Facebook Linkedin Disclaimer Privacy Policy Sitemap Cookies